Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Int J Mol Sci ; 24(7)2023 Apr 03.
Article in English | MEDLINE | ID: covidwho-2296036

ABSTRACT

'Forever' chemicals that unintendedly in the long run pollute the environment, climate change, COVID; life continuously faces all sorts of unforeseen challenges that are an inevitable side product of 'progress' [...].


Subject(s)
COVID-19 , Toxicology , Humans , Climate Change
3.
J Med Toxicol ; 18(4): 267-296, 2022 10.
Article in English | MEDLINE | ID: covidwho-2007282

ABSTRACT

The Toxicology Investigators Consortium (ToxIC) Core Registry was established by the American College of Medical Toxicology in 2010. The Core Registry collects data from participating sites with the agreement that all bedside and telehealth medical toxicology consultations will be entered. This twelfth annual report summarizes the registry's 2021 data and activity with its additional 8552 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from January 1 to December 31, 2021. Detailed data was collected from these cases and aggregated to provide information, which included demographics, reason for medical toxicology evaluation, agent and agent class, clinical signs and symptoms, treatments and antidotes administered, mortality, and whether life support was withdrawn. Gender distribution included 50.4% of cases in females, 48.2% of cases in males, and 1.4% of cases in transgender or gender non-conforming individuals. Non-opioid analgesics were the most commonly reported agent class (14.9%), followed by opioids (13.1%). Acetaminophen was the most common agent reported. Fentanyl was the most common opioid reported and was responsible for the greatest number of fatalities. There were 120 fatalities, comprising 1.4% of all cases. Major trends in demographics and exposure characteristics remained similar to past years' reports. Sub-analyses were conducted to describe new demographic characteristics, including marital status, housing status and military service, the continued COVID-19 pandemic and related toxicologic exposures, and novel substances of exposure.


Subject(s)
Analgesics, Non-Narcotic , COVID-19 , Drug Overdose , Toxicology , Acetaminophen , Analgesics, Opioid , Antidotes , Drug Overdose/diagnosis , Drug Overdose/epidemiology , Drug Overdose/therapy , Female , Fentanyl , Humans , Male , Pandemics , Registries , United States/epidemiology
4.
Toxicol Pathol ; 50(3): 397-401, 2022 04.
Article in English | MEDLINE | ID: covidwho-1759606

ABSTRACT

Histopathologic evaluation and peer review using digital whole-slide images (WSIs) is a relatively new medium for assessing nonclinical toxicology studies in Good Laboratory Practice (GLP) environments. To better understand the present and future use of digital pathology in nonclinical toxicology studies, the Society of Toxicologic Pathology (STP) formed a working group to survey STP members with the goal of creating recommendations for implementation. The survey was administered in December 2019, immediately before the COVID-19 pandemic, and the results suggested that the use of digital histopathology for routine GLP histopathology assessment was not widespread. Subsequently, in follow-up correspondence during the pandemic, many responding institutions either began investigating or adopting digital WSI systems to reduce employee exposure to COVID-19. Therefore, the working group presents the survey results as a pre-pandemic baseline data set. Recommendations for use of WSI systems in GLP environments will be the subject of a separate publication.


Subject(s)
COVID-19 , Toxicology , Communication , Humans , Pandemics , Peer Review , Policy , Toxicology/methods
5.
J Med Toxicol ; 17(4): 333-362, 2021 10.
Article in English | MEDLINE | ID: covidwho-1415107

ABSTRACT

The Toxicology Investigators Consortium (ToxIC) Registry was established by the American College of Medical Toxicology in 2010. The registry collects data from participating sites with the agreement that all bedside and telehealth medical toxicology consultation will be entered. This eleventh annual report summarizes the Registry's 2020 data and activity with its additional 6668 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from January 1 to December 31, 2020. Detailed data was collected from these cases and aggregated to provide information which included demographics, reason for medical toxicology evaluation, agent and agent class, clinical signs and symptoms, treatments and antidotes administered, mortality, and whether life support was withdrawn. Gender distribution included 50.6% cases in females, 48.4% in males, and 1.0% identifying as transgender. Non-opioid analgesics were the most commonly reported agent class, followed by opioid and antidepressant classes. Acetaminophen was once again the most common agent reported. There were 80 fatalities, comprising 1.2% of all registry cases. Major trends in demographics and exposure characteristics remained similar to past years' reports. Sub-analyses were conducted to describe race and ethnicity demographics and exposures in the registry, telemedicine encounters, and cases related to the COVID-19 pandemic.


Subject(s)
Congresses as Topic , Hazardous Substances/toxicity , Poisoning/diagnosis , Poisoning/therapy , Registries/statistics & numerical data , Research Report , Toxicology/statistics & numerical data , Adult , Aged , Aged, 80 and over , COVID-19 , Canada , Female , Humans , Israel , Male , Middle Aged , Pandemics/statistics & numerical data , SARS-CoV-2 , Thailand , United States
6.
Toxins (Basel) ; 12(10)2020 10 01.
Article in English | MEDLINE | ID: covidwho-1305799

ABSTRACT

Rapid scientific advances are increasing our understanding of the way complex biological interactions integrate to maintain homeostatic balance and how seemingly small, localized perturbations can lead to systemic effects. The 'omics movement, alongside increased throughput resulting from statistical and computational advances, has transformed our understanding of disease mechanisms and the multi-dimensional interaction between environmental stressors and host physiology through data integration into multi-dimensional analyses, i.e., integrative interactomics. This review focuses on the use of high-throughput technologies in farm animal research, including health- and toxicology-related papers. Although limited, we highlight recent animal agriculture-centered reports from the integrative multi-'omics movement. We provide an example with fescue toxicosis, an economically costly disease affecting grazing livestock, and describe how integrative interactomics can be applied to a disease with a complex pathophysiology in the pursuit of novel treatment and management approaches. We outline how 'omics techniques have been used thus far to understand fescue toxicosis pathophysiology, lay out a framework for the fescue toxicosis integrome, identify some challenges we foresee, and offer possible means for addressing these challenges. Finally, we briefly discuss how the example with fescue toxicosis could be used for other agriculturally important animal health and welfare problems.


Subject(s)
Animal Feed/toxicity , Environmental Exposure/adverse effects , Epichloe/metabolism , Ergot Alkaloids/toxicity , Ergotism/veterinary , Lolium/microbiology , Metabolomics , Toxicology , Animal Husbandry , Animal Welfare , Animals , Ergot Alkaloids/metabolism , Ergotism/metabolism , Ergotism/microbiology , Ergotism/prevention & control , Gastrointestinal Microbiome , High-Throughput Screening Assays
8.
Toxicol Sci ; 179(2): 147-148, 2021 01 28.
Article in English | MEDLINE | ID: covidwho-1052215
9.
Basic Clin Pharmacol Toxicol ; 128(1): 3, 2021 01.
Article in English | MEDLINE | ID: covidwho-1024186
11.
Toxicol Pathol ; 48(8): 944-948, 2020 12.
Article in English | MEDLINE | ID: covidwho-844333

ABSTRACT

The coronavirus disease 2019 pandemic has affected business on numerous fronts in unprecedented and abrupt ways. From site closures and local "stay-at-home orders" to travel advisories and restrictions, the day-to-day practice of toxicologic pathology has been impacted dramatically and rapidly. A critical function of Toxicologic Pathologists is performing pathology peer review for nonclinical studies. Traditionally, corroborating the findings of histological assessment could be achieved through shipment of histopathological slides to the peer review pathologist, or by the peer review pathologist traveling to the location of the slides (eg, the test facility). Since early 2020, many pathologists have been unable to perform the latter due to local, regional, national, test facility, company, and/or personal restrictions. The disruption for some has been minimal, while others are working from home for the first time. We recommend that contingency plans for all peer review procedures and personnel should be in-place to accommodate sudden and unexpected workflow transitions. Now, more than ever, approaching peer reviews with enhanced adaptability will help ensure success.


Subject(s)
COVID-19 , Pathology, Clinical/methods , Peer Review/methods , Toxicology/methods , Humans , SARS-CoV-2 , Workflow
12.
J Med Toxicol ; 16(4): 353-355, 2020 10.
Article in English | MEDLINE | ID: covidwho-728288

ABSTRACT

The American College of Medical Toxicology (ACMT) 2020 Annual Scientific Meeting (ASM) was scheduled to be held in New York City, March 12-15, 2020, and had the largest conference registration in the history of ACMT's ASM. In the week prior to the conference, the severity of the COVID-19 pandemic in New York City and the USA was becoming apparent. On the first day of the conference, organizers canceled the live portion of the meeting and converted the conference into an entirely virtual meeting. We discuss the challenges of holding a virtual conference, future directions for online meetings, and why our conference was ultimately successful.


Subject(s)
Betacoronavirus , Congresses as Topic , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Toxicology , User-Computer Interface , COVID-19 , Humans , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL